AZOLO TRIAZINES AND PYRIMIDINES
Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopath...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ARVANITIS, ARGYRIOS, GEORGIOUS CHORVAT, ROBERT, JOHN |
| description | Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Cette invention concerne des inhibiteurs de facteur de libération de corticotropine, lesquels correspondent à la formule (I) ou (II). Cette invention concerne également l'utilisation de ces inhibiteurs dans le traitement de l'anxiété, de dépressions ainsi que d'autres troubles psychiatriques et neurologiques. Ces inhibiteurs peuvent également être utilisés dans le traitement de maladies immunologiques, cardio-vasculaires ou touchant le coeur, ainsi que dans le traitement de l'hypersensibilité du côlon associée à des problèmes psychopathologiques et au stress. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO9803510A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO9803510A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO9803510A13</originalsourceid><addsrcrecordid>eNrjZJB3jPL38VcICfJ0jPL0cw1WcPRzUQiIDPL09XQB8XkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXy4v6WFgbGpoYGjoTERSgCoLCGC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AZOLO TRIAZINES AND PYRIMIDINES</title><source>esp@cenet</source><creator>ARVANITIS, ARGYRIOS, GEORGIOUS ; CHORVAT, ROBERT, JOHN</creator><creatorcontrib>ARVANITIS, ARGYRIOS, GEORGIOUS ; CHORVAT, ROBERT, JOHN</creatorcontrib><description>Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Cette invention concerne des inhibiteurs de facteur de libération de corticotropine, lesquels correspondent à la formule (I) ou (II). Cette invention concerne également l'utilisation de ces inhibiteurs dans le traitement de l'anxiété, de dépressions ainsi que d'autres troubles psychiatriques et neurologiques. Ces inhibiteurs peuvent également être utilisés dans le traitement de maladies immunologiques, cardio-vasculaires ou touchant le coeur, ainsi que dans le traitement de l'hypersensibilité du côlon associée à des problèmes psychopathologiques et au stress.</description><edition>6</edition><language>eng ; fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SUGARS</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980129&DB=EPODOC&CC=WO&NR=9803510A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980129&DB=EPODOC&CC=WO&NR=9803510A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ARVANITIS, ARGYRIOS, GEORGIOUS</creatorcontrib><creatorcontrib>CHORVAT, ROBERT, JOHN</creatorcontrib><title>AZOLO TRIAZINES AND PYRIMIDINES</title><description>Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Cette invention concerne des inhibiteurs de facteur de libération de corticotropine, lesquels correspondent à la formule (I) ou (II). Cette invention concerne également l'utilisation de ces inhibiteurs dans le traitement de l'anxiété, de dépressions ainsi que d'autres troubles psychiatriques et neurologiques. Ces inhibiteurs peuvent également être utilisés dans le traitement de maladies immunologiques, cardio-vasculaires ou touchant le coeur, ainsi que dans le traitement de l'hypersensibilité du côlon associée à des problèmes psychopathologiques et au stress.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB3jPL38VcICfJ0jPL0cw1WcPRzUQiIDPL09XQB8XkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSXy4v6WFgbGpoYGjoTERSgCoLCGC</recordid><startdate>19980129</startdate><enddate>19980129</enddate><creator>ARVANITIS, ARGYRIOS, GEORGIOUS</creator><creator>CHORVAT, ROBERT, JOHN</creator><scope>EVB</scope></search><sort><creationdate>19980129</creationdate><title>AZOLO TRIAZINES AND PYRIMIDINES</title><author>ARVANITIS, ARGYRIOS, GEORGIOUS ; CHORVAT, ROBERT, JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO9803510A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1998</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>ARVANITIS, ARGYRIOS, GEORGIOUS</creatorcontrib><creatorcontrib>CHORVAT, ROBERT, JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ARVANITIS, ARGYRIOS, GEORGIOUS</au><au>CHORVAT, ROBERT, JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AZOLO TRIAZINES AND PYRIMIDINES</title><date>1998-01-29</date><risdate>1998</risdate><abstract>Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
Cette invention concerne des inhibiteurs de facteur de libération de corticotropine, lesquels correspondent à la formule (I) ou (II). Cette invention concerne également l'utilisation de ces inhibiteurs dans le traitement de l'anxiété, de dépressions ainsi que d'autres troubles psychiatriques et neurologiques. Ces inhibiteurs peuvent également être utilisés dans le traitement de maladies immunologiques, cardio-vasculaires ou touchant le coeur, ainsi que dans le traitement de l'hypersensibilité du côlon associée à des problèmes psychopathologiques et au stress.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO9803510A1 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SUGARS |
| title | AZOLO TRIAZINES AND PYRIMIDINES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T18%3A10%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ARVANITIS,%20ARGYRIOS,%20GEORGIOUS&rft.date=1998-01-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO9803510A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |